Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Reeves

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Psychiatry Research. Neuroimaging|December 31, 2019
Neuroimaging correlates of false memory in 'Alzheimer's disease: A preliminary systematic reviewEmma McLachlan, Salina Rai, Ahmed Al-Shihabi, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 20, 2019
Misidentification Subtype of Alzheimer's Disease Psychosis Predicts a Faster Cognitive DeclineFabrizia D'Antonio, Suzanne Reeves, Yucheng Sheng, et al.
Brain : a Journal of Neurology|November 14, 2020
Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's diseaseKathy Y Liu, Suzanne Reeves, Kirsty E McAleese, et al.
Neuroscience and Biobehavioral Reviews|January 15, 2022
Paranoid and misidentification subtypes of psychosis in dementiaDanielle Pearce, Rebecca L Gould, Matthew Roughley, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 5, 2021
Pharmacological treatment trials of agitation in Alzheimer's disease: A systematic review of ClinicalTrials.gov registered trialsKathy Y Liu, Anya Borissova, Jansher Mahmood, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 21, 2021
Disrupted reward processing in Parkinson's disease and its relationship with dopamine state and neuropsychiatric syndromes: a systematic review and meta-analysisHarry Costello, Alex J Berry, Suzanne Reeves, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 22, 2025
Cognitive effects of dopaminergic treatment in Alzheimer's disease: Systematic review and meta-analysisCristina Bonet Olivares, Michael C B David, Marta Estrada Obeso, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|February 21, 2017
Lack of Early Improvement with Antipsychotics is a Marker for Subsequent Nonresponse in Behavioral and Psychological Symptoms of Dementia: Analysis of CATIE-AD DataKazunari Yoshida, Rachel Roberts, Takefumi Suzuki, et al.
The Journal of Clinical Psychiatry|October 19, 2017
Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD DataChisa Ozawa, Rachel Roberts, Kazunari Yoshida, et al.
Psychopharmacology|August 3, 2016
A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer's diseaseSuzanne Reeves, Julie Bertrand, Fabrizia D'Antonio, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Psychiatry Research. Neuroimaging|December 31, 2019
Neuroimaging correlates of false memory in 'Alzheimer's disease: A preliminary systematic reviewEmma McLachlan, Salina Rai, Ahmed Al-Shihabi, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 20, 2019
Misidentification Subtype of Alzheimer's Disease Psychosis Predicts a Faster Cognitive DeclineFabrizia D'Antonio, Suzanne Reeves, Yucheng Sheng, et al.
Brain : a Journal of Neurology|November 14, 2020
Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's diseaseKathy Y Liu, Suzanne Reeves, Kirsty E McAleese, et al.
Neuroscience and Biobehavioral Reviews|January 15, 2022
Paranoid and misidentification subtypes of psychosis in dementiaDanielle Pearce, Rebecca L Gould, Matthew Roughley, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 5, 2021
Pharmacological treatment trials of agitation in Alzheimer's disease: A systematic review of ClinicalTrials.gov registered trialsKathy Y Liu, Anya Borissova, Jansher Mahmood, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 21, 2021
Disrupted reward processing in Parkinson's disease and its relationship with dopamine state and neuropsychiatric syndromes: a systematic review and meta-analysisHarry Costello, Alex J Berry, Suzanne Reeves, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 22, 2025
Cognitive effects of dopaminergic treatment in Alzheimer's disease: Systematic review and meta-analysisCristina Bonet Olivares, Michael C B David, Marta Estrada Obeso, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|February 21, 2017
Lack of Early Improvement with Antipsychotics is a Marker for Subsequent Nonresponse in Behavioral and Psychological Symptoms of Dementia: Analysis of CATIE-AD DataKazunari Yoshida, Rachel Roberts, Takefumi Suzuki, et al.
The Journal of Clinical Psychiatry|October 19, 2017
Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD DataChisa Ozawa, Rachel Roberts, Kazunari Yoshida, et al.
Psychopharmacology|August 3, 2016
A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer's diseaseSuzanne Reeves, Julie Bertrand, Fabrizia D'Antonio, et al.
Pageof 5